157 related articles for article (PubMed ID: 8340401)
21. Enzymic control of collagen fibril shape.
Holmes DF; Watson RB; Chapman JA; Kadler KE
J Mol Biol; 1996 Aug; 261(2):93-7. PubMed ID: 8757278
[TBL] [Abstract][Full Text] [Related]
22. Ehlers-Danlos syndrome type VIII: biochemical, stereological and immunocytochemical studies on dermis from a child with clinical signs of Ehlers-Danlos syndrome and a family history of premature loss of permanent teeth.
Dyne KM; Vitellaro-Zuccarello L; Bacchella L; Lanzi G; Cetta G
Br J Dermatol; 1993 Apr; 128(4):458-63. PubMed ID: 8494762
[TBL] [Abstract][Full Text] [Related]
23. Ehlers-Danlos syndrome type VIIA and VIIB result from splice-junction mutations or genomic deletions that involve exon 6 in the COL1A1 and COL1A2 genes of type I collagen.
Byers PH; Duvic M; Atkinson M; Robinow M; Smith LT; Krane SM; Greally MT; Ludman M; Matalon R; Pauker S; Quanbeck D; Schwarze U
Am J Med Genet; 1997 Oct; 72(1):94-105. PubMed ID: 9295084
[TBL] [Abstract][Full Text] [Related]
24. Amino and carboxyl propeptides in bone collagen fibrils during embryogenesis.
Fleischmajer R; Perlish JS; Olsen BR
Cell Tissue Res; 1987 Jan; 247(1):105-9. PubMed ID: 3829111
[TBL] [Abstract][Full Text] [Related]
25. COL5A1 exon 14 splice acceptor mutation causes a functional null allele, haploinsufficiency of alpha 1(V) and abnormal heterotypic interstitial fibrils in Ehlers-Danlos syndrome II.
Bouma P; Cabral WA; Cole WG; Marini JC
J Biol Chem; 2001 Apr; 276(16):13356-64. PubMed ID: 11278977
[TBL] [Abstract][Full Text] [Related]
26. Low production of procollagen III by skin fibroblasts from patients with Ehlers-Danlos syndrome type IV is not caused by decreased levels of procollagen III mRNA.
Aumailley M; Pöschl E; Martin GR; Yamada Y; Müller PK
Eur J Clin Invest; 1988 Apr; 18(2):207-12. PubMed ID: 3133227
[TBL] [Abstract][Full Text] [Related]
27. Abnormal collagen fibril structure in the gravis form (type I) of Ehlers-Danlos syndrome.
Vogel A; Holbrook KA; Steinmann B; Gitzelmann R; Byers PH
Lab Invest; 1979 Feb; 40(2):201-6. PubMed ID: 431039
[TBL] [Abstract][Full Text] [Related]
28. A heterozygous collagen defect in a variant of the Ehlers-Danlos syndrome type VII. Evidence for a deleted amino-telopeptide domain in the pro-alpha 2(I) chain.
Eyre DR; Shapiro FD; Aldridge JF
J Biol Chem; 1985 Sep; 260(20):11322-9. PubMed ID: 2993307
[TBL] [Abstract][Full Text] [Related]
29. Mutations in the COL5A1 gene are causal in the Ehlers-Danlos syndromes I and II.
De Paepe A; Nuytinck L; Hausser I; Anton-Lamprecht I; Naeyaert JM
Am J Hum Genet; 1997 Mar; 60(3):547-54. PubMed ID: 9042913
[TBL] [Abstract][Full Text] [Related]
30. Collagen fibril formation during embryogenesis.
Fleischmajer R; Olsen BR; Timpl R; Perlish JS; Lovelace O
Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3354-8. PubMed ID: 6574488
[TBL] [Abstract][Full Text] [Related]
31. Identification of a mutation that causes exon skipping during collagen pre-mRNA splicing in an Ehlers-Danlos syndrome variant.
Weil D; Bernard M; Combates N; Wirtz MK; Hollister DW; Steinmann B; Ramirez F
J Biol Chem; 1988 Jun; 263(18):8561-4. PubMed ID: 2454224
[TBL] [Abstract][Full Text] [Related]
32. Clinical features of an affected father and daughter with Ehlers-Danlos syndrome type VIIB.
Pope FM; Nicholls AC; Palan A; Kwee ML; De Groot WP; Hausmann R
Br J Dermatol; 1992 Jan; 126(1):77-82. PubMed ID: 1536766
[TBL] [Abstract][Full Text] [Related]
33. Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV.
Schwarze U; Schievink WI; Petty E; Jaff MR; Babovic-Vuksanovic D; Cherry KJ; Pepin M; Byers PH
Am J Hum Genet; 2001 Nov; 69(5):989-1001. PubMed ID: 11577371
[TBL] [Abstract][Full Text] [Related]
34. Building collagen molecules, fibrils, and suprafibrillar structures.
Hulmes DJ
J Struct Biol; 2002; 137(1-2):2-10. PubMed ID: 12064927
[TBL] [Abstract][Full Text] [Related]
35. Ehlers-Danlos syndrome type VIIB. Deletion of 18 amino acids comprising the N-telopeptide region of a pro-alpha 2(I) chain.
Wirtz MK; Glanville RW; Steinmann B; Rao VH; Hollister DW
J Biol Chem; 1987 Dec; 262(34):16376-85. PubMed ID: 3680255
[TBL] [Abstract][Full Text] [Related]
36. Case report and study of collagen metabolism in Ehlers-Danlos syndrome type II.
Kojima T; Shinkai H; Fujita M; Morita E; Okamoto S
J Dermatol; 1988 Apr; 15(2):155-60. PubMed ID: 3049731
[No Abstract] [Full Text] [Related]
37. Assembly in vitro of thin and thick fibrils of collagen II from recombinant procollagen II. The monomers in the tips of thick fibrils have the opposite orientation from monomers in the growing tips of collagen I fibrils.
Fertala A; Holmes DF; Kadler KE; Sieron AL; Prockop DJ
J Biol Chem; 1996 Jun; 271(25):14864-9. PubMed ID: 8662997
[TBL] [Abstract][Full Text] [Related]
38. [Various characteristics of the structure and synthesis of procollagens produced by cultured skin fibroblasts from patients with Danlos-Ehlers syndrome type I].
Sokolov BP; Sher BM; Lomova TIu; Kukharenko VI; Blinnikova OE
Mol Gen Mikrobiol Virusol; 1987 Jan; (1):19-23. PubMed ID: 3561422
[TBL] [Abstract][Full Text] [Related]
39. Growing tips of type I collagen fibrils formed in vitro are near-paraboloidal in shape, implying a reciprocal relationship between accretion and diameter.
Holmes DF; Chapman JA; Prockop DJ; Kadler KE
Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9855-9. PubMed ID: 1409712
[TBL] [Abstract][Full Text] [Related]
40. Formation of collagen fibrils in vitro by cleavage of procollagen with procollagen proteinases.
Miyahara M; Njieha FK; Prockop DJ
J Biol Chem; 1982 Jul; 257(14):8442-8. PubMed ID: 6806297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
